Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Soludent** is a commercial chlorhexidine-containing mouthrinse recorded as an intervention in a randomized, double-blind clinical study at Hôpital Militaire de Rabat for control of dental plaque. The associated study compared two commercial chlorhexidine mouthrinses: an alcohol-based 0.12% chlorhexidine formulation and an alcohol-free 0.1% chlorhexidine formulation containing 0.1% formaldehyde. The public trial and publication records do not unambiguously assign which of these two formulations corresponds to Soludent; therefore, its exact concentration, alcohol content, and formaldehyde content are not assigned here. Chlorhexidine is a cationic bisbiguanide oral antiseptic that reduces plaque-associated oral bacteria by disrupting bacterial cell membranes and cellular contents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Soludent.